Urology Doctors in Bloomington, IL Accepting Medicare

6 Urology doctors found. Showing 1 - 6

Dr. Benjamin J Leak, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Eastland Dr, Suite B, Bloomington, IL 61701 Phone: 309-663-9424    Fax: 309-663-6350

Dr. Mariano Villalon Tolentino Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3000    Fax: 309-664-3026

Dr. Samuel Anthony Grampsas, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3000    Fax: 309-664-3026

Dr. Scott Christopher Morgan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3000    Fax: 309-664-3026

Dr. Thomas B Kulb, M.D., Urology Medicare: Not Enrolled in Medicare Practice Location: 1401 Eastland Dr, Suite B, Bloomington, IL 61701 Phone: 309-663-9424    Fax: 309-663-6350

Dr. Vicken S Chalian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Eastland Dr, Suite B, Bloomington, IL 61701 Phone: 309-663-9424    Fax: 309-663-6350

News Archive

Macrophages allow entry of HIV in the urethra

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Brain abnormalities in people at familial risk of schizophrenia and bipolar disorder emerge in unique patterns, despite the symptom and genetic overlap of the disorders, according to a study in Biological Psychiatry, published by Elsevier.

FDA: Seven MDIs for treating asthma and COPD to be phased out

The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.

AutoGenomics awarded ISO 13485 certification for quality management system

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that the organization has been awarded the ISO 13485 certification in recognition of its outstanding quality management system throughout the organization. TUV SUD America Inc. was the Certification Body.

Read more Medical News

› Verified 5 days ago